OPRM1 and cancer: Associations between analgesic response and the DNA methylation level of the opioid mu receptor (OPRM1) gene (CpG sites 1–5 selected in the promoter region) were evaluated in 345 long opioid‐treated chronic non cancer pain: cases with OUD (n = 67) and controls (without OUD, n = 278).